Treatment of Painful Digital Neuroma Using A Pedicled Nerve Flap

NCT01684839 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-02-15

Study results available
· View outcomes & findings →

Summary

Neuroma excision and digital nerve reconstruction remain the best option for the treatment of Painful Digital Neuroma (PDN). When the distal nerve end is preserved, conventional nonvascularized nerve grafting is the primary option to bridge the defect. The investigators hypothesize the pedicled nerve flap taken from the dorsal branch of the homolateral digital nerve is better than conventional methods for reconstruction of the digital nerve defect after painful neuroma resection.

This study reports treatment of painful digital neuroma using a pedicled nerve flap taken from the dorsal branch of homolateral digital nerve. From May 2007 to March 2010, the patients had previous nerve injuries with or without nerve repair. The mechanisms of injury include sharp cut, avulsion and crush. The defects were between the middle of the distal phalanx and the palmar digital crease.

Conditions

  • Painful Digital Neuroma

Interventions

DEVICE

Pedicled nerve flap

This nerve flap is a vascularized nerve graft

Sponsors & Collaborators

  • Chinese PLA General Hospital

    collaborator OTHER
  • The Second Hospital of Qinhuangdao

    collaborator OTHER
  • The Second Hospital of Tangshan

    lead OTHER

Principal Investigators

  • Gang Zhao, MD. · The Second Hospital of Tangshan

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-05-31
Primary Completion
2010-03-31
Completion
2012-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01684839 on ClinicalTrials.gov